Atıf Formatları
Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. Sevim Nalkıran, "Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis," Eurasian Congress on Molecular Biotechnology , Trabzon, Turkey, pp.17, 2019

Sevim Nalkıran, H. 2019. Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis. Eurasian Congress on Molecular Biotechnology , (Trabzon, Turkey), 17.

Sevim Nalkıran, H., (2019). Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis . Eurasian Congress on Molecular Biotechnology (pp.17). Trabzon, Turkey

Sevim Nalkıran, HATİCE. "Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis," Eurasian Congress on Molecular Biotechnology, Trabzon, Turkey, 2019

Sevim Nalkıran, HATİCE S. . "Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis." Eurasian Congress on Molecular Biotechnology , Trabzon, Turkey, pp.17, 2019

Sevim Nalkıran, H. (2019) . "Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis." Eurasian Congress on Molecular Biotechnology , Trabzon, Turkey, p.17.

@conferencepaper{conferencepaper, author={HATİCE SEVİM NALKIRAN}, title={Prognostic role of PD-L1 expression in anti-PD-1/PD-L1 immunotherapy for bladder cancer patients, a meta-analysis}, congress name={Eurasian Congress on Molecular Biotechnology}, city={Trabzon}, country={Turkey}, year={2019}, pages={17} }